No. of Cases (current year) and percentage change vs. previous year (persons)
Statistically significant difference in 2020 compared to 2017-2019 |
No statistical significant difference in 2020 compared to 2017-2019 |
|
Country average (population) |
Country average (country) |
England |
Scotland |
Northern Ireland |
Wales |
All invasive xnmsc |
345,882 (-10.3%) |
-10.1% |
288753 (-10.2%) |
30395 (-9.7%) |
9273 (-8%) |
17461 (-12.6%) |
All xnmsc 0-24 |
3,582 (-5.1%) |
-2.3% |
3043 (-5.5%) |
259 (-9.2%) |
108 (-5%) |
172 (10.5%) |
All xnmsc 25-59 |
78,872 (-11.7%) |
-12.0% |
66157 (-11.7%) |
6870 (-11%) |
2194 (-13.6%) |
3651 (-11.7%) |
All xnmsc 60-79 |
184,754 (-10.8%) |
-10.3% |
153320 (-10.8%) |
16675 (-10.2%) |
5062 (-6.2%) |
9697 (-13.8%) |
All xnmsc 80+ |
78,674 (-7.6%) |
-7.9% |
66233 (-7.4%) |
6591 (-7.1%) |
1909 (-5.8%) |
3941 (-11.2%) |
All registrations |
539,773 (-14.2%) |
-15.7% |
449788 (-13.8%) |
46591 (-15%) |
15505 (-15.1%) |
27889 (-18.9%) |
Haematology |
30,707 (-9.5%) |
-9.6% |
26214 (-9.5%) |
2321 (-9.2%) |
817 (-9.3%) |
1355 (-10.6%) |
Head and Neck |
12,213 (-4.3%) |
-9.3% |
10020 (-3.2%) |
1228 (-5.3%) |
306 (-17.5%) |
659 (-11.1%) |
Lower GI |
44,420 (-6.6%) |
-9.9% |
37315 (-5.2%) |
3632 (-15.7%) |
1176 (-8.1%) |
2297 (-10.7%) |
Upper GI |
14,875 (-6.6%) |
-7.7% |
12271 (-6.4%) |
1434 (-5.7%) |
377 (-7.8%) |
793 (-11%) |
HPB |
20,396 (2.3%) |
3.4% |
17040 (2.2%) |
1770 (2.7%) |
556 (9.3%) |
1030 (-0.7%) |
Trachea, Bronchus & Lung |
45,801 (-7%) |
-6.8% |
37237 (-6.7%) |
4933 (-8.9%) |
1316 (-3%) |
2315 (-8.3%) |
Melanoma of skin |
14,741 (-15.9%) |
-16.9% |
12477 (-15.8%) |
1183 (-14.5%) |
324 (-18.3%) |
757 (-18.8%) |
Breast |
48,204 (-15.2%) |
-13.3% |
40192 (-15.6%) |
4312 (-11.9%) |
1363 (-9.5%) |
2337 (-16.3%) |
Cervix |
2,840 (-12.8%) |
-15.3% |
2371 (-11.8%) |
266 (-18.2%) |
73 (-12.7%) |
130 (-18.4%) |
Other Female Genitals |
18,074 (-6%) |
-8.8% |
15088 (-5.6%) |
1583 (-5.3%) |
449 (-17%) |
954 (-7.3%) |
Prostate |
42,895 (-22.1%) |
-16.8% |
36016 (-23.1%) |
3394 (-13.7%) |
1224 (-5%) |
2261 (-25.3%) |
Kidney |
12,397 (-8.9%) |
-12.9% |
10444 (-8.1%) |
1058 (-11.5%) |
296 (-21.8%) |
599 (-10.3%) |
Bladder |
10,250 (-2.1%) |
-5.5% |
8752 (-1.4%) |
800 (-2.4%) |
218 (-7.8%) |
480 (-10.6%) |
Brain and CNS |
5,439 (-5.5%) |
-6.1% |
4585 (-5.1%) |
411 (-12.1%) |
149 (-5.3%) |
294 (-1.8%) |
Thyroid & other endocrine glands |
3,923 (-11.7%) |
-15.5% |
3379 (-10.6%) |
274 (-20.1%) |
160 (1.7%) |
110 (-32.9%) |
CUP |
7,717 (-4.4%) |
0.0% |
6179 (-6%) |
798 (2.1%) |
181 (-0.7%) |
559 (4.7%) |
Other invasive cancer |
10,990 (-7.2%) |
-6.6% |
9173 (-7.6%) |
998 (-4%) |
288 (-10.6%) |
531 (-4.2%) |
Breast in situ |
5,853 (-30.8%) |
-31.7% |
5099 (-30.4%) |
326 (-32.6%) |
194 (-23.4%) |
234 (-40.3%) |
Cervix in situ |
19,525 (-22.2%) |
-33.6% |
16868 (-18.4%) |
1152 (-45.2%) |
594 (-35.7%) |
911 (-35.3%) |
Other tumours |
44,363 (-17.7%) |
-22.6% |
35185 (-15.9%) |
5141 (-21.8%) |
2272 (-22.1%) |
1765 (-30.8%) |
Other non-melanoma skin cancer |
1984 (-2.8%) |
-2.7% |
1647 (-1.9%) |
135 (-22.7%) |
119 (14.1%) |
83 (-0.4%) |
Basal cell carcinoma |
84241 (-26.8%) |
-29.2% |
71364 (-26.1%) |
5827 (-29.1%) |
2036 (-28.3%) |
5014 (-33%) |
Squamous cell carcinoma |
37925 (-2.6%) |
-3.8% |
30872 (-2.7%) |
3615 (1.3%) |
1017 (-10.7%) |
2421 (-3.2%) |